Who are Etonogestrel/ethinyl estradiol vaginal ring's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): desogestrel/ethinyl estradiol, Nomegestrol Acetate / Estradiol, Continuous OC (EE/DROS), Phase 3 NOMAC-E2 "Batch A", Drospirenone and Ethinyl Estradiol tablets, Intermittent OC (EE/DROS).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/etonogestrel-ethinyl-estradiol-vaginal-ring.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Etonogestrel/ethinyl estradiol vaginal ring — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Etonogestrel/ethinyl estradiol vaginal ring (Etonogestrel/ethinyl estradiol vaginal ring) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combined hormonal contraceptive. Area: Contraception / Reproductive Health.

marketed Combined hormonal contraceptive Progesterone receptor, estrogen receptor Contraception / Reproductive Health Small molecule Live · refreshed every 30 min

Target snapshot

Etonogestrel/ethinyl estradiol vaginal ring (Etonogestrel/ethinyl estradiol vaginal ring) — Andrea Roe, MD, MPH. Etonogestrel and ethinyl estradiol work together to prevent ovulation and thicken cervical mucus, providing contraceptive protection through a vaginal ring delivery system.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Etonogestrel/ethinyl estradiol vaginal ring TARGET	Etonogestrel/ethinyl estradiol vaginal ring	Andrea Roe, MD, MPH	marketed	Combined hormonal contraceptive	Progesterone receptor, estrogen receptor
desogestrel/ethinyl estradiol	desogestrel/ethinyl estradiol	Teva Branded Pharmaceutical Products R&D, Inc.	marketed	Combined oral contraceptive	Progesterone receptor, estrogen receptor
Nomegestrol Acetate / Estradiol	Nomegestrol Acetate / Estradiol	University of Palermo	marketed	Combined oral contraceptive	Progesterone receptor, Estrogen receptor
Continuous OC (EE/DROS)	Continuous OC (EE/DROS)	University of North Carolina, Chapel Hill	marketed	Oral contraceptive	Progesterone receptor, estrogen receptor
Phase 3 NOMAC-E2 "Batch A"	Phase 3 NOMAC-E2 "Batch A"	Organon and Co	marketed	Combined oral contraceptive	Progesterone receptor, estrogen receptor
Drospirenone and Ethinyl Estradiol tablets	Drospirenone and Ethinyl Estradiol tablets	Hansoh BioMedical R&D Company	marketed	Combined oral contraceptive	Progesterone receptor, estrogen receptor
Intermittent OC (EE/DROS)	Intermittent OC (EE/DROS)	University of North Carolina, Chapel Hill	marketed	Oral contraceptive	Progesterone receptor, estrogen receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combined hormonal contraceptive class)

Andrea Roe, MD, MPH · 1 drug in this class
Organon and Co · 1 drug in this class
University of Pittsburgh · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Etonogestrel/ethinyl estradiol vaginal ring — Competitive Intelligence Brief. https://druglandscape.com/ci/etonogestrel-ethinyl-estradiol-vaginal-ring. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab